Invention Grant
- Patent Title: Enhanced bimatoprost ophthalmic solution
-
Application No.: US13551379Application Date: 2012-07-17
-
Publication No.: US08524777B2Publication Date: 2013-09-03
- Inventor: Chin-Ming Chang , James N. Chang , Rhett M. Schiffman , R. Scott Jordan , Joan-En Chang-Lin
- Applicant: Chin-Ming Chang , James N. Chang , Rhett M. Schiffman , R. Scott Jordan , Joan-En Chang-Lin
- Applicant Address: US CA Irvine
- Assignee: Allergan Inc.
- Current Assignee: Allergan Inc.
- Current Assignee Address: US CA Irvine
- Agency: Allergan, Inc.
- Agent John E. Wurst
- Main IPC: A61K31/14
- IPC: A61K31/14 ; A61K31/557 ; A61K31/5575
Abstract:
A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein.
Public/Granted literature
- US20120289603A1 ENHANCED BIMATOPROST OPHTHALMIC SOLUTION Public/Granted day:2012-11-15
Information query
